AMLo Biosciences
BioTech/Drugs - N/A, N/A, UK
AMLo Biosciences Employees
AMLo Biosciences Senior Management
AMLo Biosciences Details
Formed in late 2017, AMLo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify patients' true risk of disease progression. Those patients who are genuinely at low-risk of disease spread can be provided reassurance and better-informed follow-up care, while those identified at risk of metastasis are enabled to receive timely treatment.The test under development – AMBLor® – will be simple to use and fits seamlessly into current diagnostic practice. AMLo Biosciences has been founded by a team with an internationally acclaimed research track record in the melanoma field, through identification of translational biomarkers, drug discovery & development and the building of biotech companies.
AMLo Biosciences Technologies
Email Providers
Outlook
Fonts
Google Font API
Tag Management
Google Tag Manager
Other
Google Places
Online Video Platforms
YouTube